ID
38416
Beschreibung
Study ID: 103414 Clinical Study ID: 103414 Study Title: A Multicenter, Randomized, Double-blind, Parallel Group Trial to Demonstrate the Efficacy of Fondaparinux Sodium in Association With Intermittent Pneumatic Compression (IPC) Versus IPC Used Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal surgery Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00038961 https://clinicaltrials.gov/ct2/show/NCT00038961 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Fondaparinux Sodium Trade Name: Fondaparinux Sodium Study Indication: Thrombosis This phase III placebo-controlled trial studies the efficacy and safety of Fondaparinux as an additional prevention measure of venous thromboembolic events (VTE) in patients above the age of 40 with intermediate or high VTE risk undergoing abdominal surgery. The study consists of a Screening Visit (Visit 0), the baseline visit on Day 1, the day of the surgery (Visit 1), the treatment period (denoted in its entirety as Visit 2) consisting of administration of Fondaparinux (2.5mg subcutaneously once daily) or placebo starting on Day 1 and continuing at least up to Day 5, possibly up to Day 9, in parallel to intermittent pneumatic compression and possibly elastic stockings, followed by a mandatory bilateral venography no longer than 24 hours after study drug cessation, and finally a Follow-up Visit (Visit 3) on Day 30 +/- 2. This form is to be filled in at the Follow-up Visit (Visit 3) on Day 30 +/- 2 or can be used for the last contact information.
Link
https://clinicaltrials.gov/ct2/show/NCT00038961
Stichworte
Versionen (1)
- 16.10.19 16.10.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
16. Oktober 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Fondaparinux in Addition to Intermittent Pneumatic Compression in Abdominal Surgery Patients at VTE Risk - NCT00038961
Follow-Up
- StudyEvent: ODM
Beschreibung
Follow-Up Record Day 30 ± 2 or Last Contact Information
Alias
- UMLS CUI-1
- C1522577
- UMLS CUI-2
- C1517741
- UMLS CUI-3
- C0332158
Beschreibung
Type of Follow-Up contact
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1522577
- UMLS CUI [1,2]
- C0332158
- UMLS CUI [1,3]
- C0332307
Beschreibung
Follow-Up contact made by
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1522577
- UMLS CUI [1,2]
- C1705415
Beschreibung
Follow-Up contact with
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1522577
- UMLS CUI [1,2]
- C0332158
Ähnliche Modelle
Follow-Up
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
C1517741 (UMLS CUI-2)
C0332158 (UMLS CUI-3)
C0332158 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C1705415 (UMLS CUI [1,2])